#14 - Robert Lustig, M.D., M.S.L.: fructose, processed food, NAFLD, and changing the food system

#14 - Robert Lustig, M.D., M.S.L.: fructose, processed food, NAFLD, and changing the food system

In this episode, Rob Lustig — a researcher, an expert in fructose metabolism, and a former pediatric endocrinologist — discusses what's wrong with the current food environment, and what we can do to reduce our chances of becoming part of the obesity, diabetes, metabolic syndrome, and nonalcoholic fatty liver disease (NAFLD) epidemics. Rob recently earned a Master of Studies in Law because he believes that educating people about sugar from a scientific standpoint is only half the equation: the other half involves changing policy, which he explains in this episode.

We discuss:

  • What's the difference between glucose and fructose? [7:00];
  • Do we have biomarkers that can give us some indication of average exposure to fructose over a given period of time? [14:20];
  • What's the difference between ALT and AST? [18:45];
  • Inflammation, endothelial function, and uric acid [21:30];
  • Is there something that fructose does better than glucose? [23:45];
  • For children that undergo a remarkable shift from metabolic health to metabolic derangement, is there a concern that these kids suffer an epigenetic hit that makes it harder for them later in life? [26:15];
  • How many times do you have to introduce a savory food vs a sugary food to an infant before they will accept it? [29:30];
  • How are alcohol and fructose similar in how they affect the brain? [33:51];
  • Advice for parents and kids for creating a sustainable environment that's going to prevent them from running into metabolic problems [40:30];
  • Why do some populations have a higher risk for NAFLD? [45:42];
  • What causes NAFLD? [48:45];
  • Is insulin resistance the result of NAFLD or is NAFLD the result of insulin resistance? [56:00];
  • HRV, cortisol, and norepinephrine [1:00:30];
  • What are the actual mechanisms that links metabolic syndrome, insulin resistance, fatty liver, and type 2 diabetes? [1:03:00];
  • Is the food industry still saying that all calories contribute equally to adiposity and insulin resistance? [1:09:00];
  • What is the difference between soluble and insoluble fiber and why do you need both? [1:13:00];
  • How can we change the food system when 10 companies control almost 90 percent of the Calories we consume in the US? [1:15:00]; and
  • More.

Learn more at www.PeterAttiaMD.com

Connect with Peter on Facebook | Twitter | Instagram.

Avsnitt(434)

#326 - AMA #65: Red light therapy: promising applications, mixed evidence, and impact on health and aging

#326 - AMA #65: Red light therapy: promising applications, mixed evidence, and impact on health and aging

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this "Ask Me Anything" (AMA) episode, Peter dives into the worl...

18 Nov 202415min

#325 ‒ Peter's key takeaways on bone health, calorie restriction and energy balance, dopamine and addiction, gene editing, and testosterone therapy safety with a prostate cancer diagnosis | Quarterly Podcast Summary #3

#325 ‒ Peter's key takeaways on bone health, calorie restriction and energy balance, dopamine and addiction, gene editing, and testosterone therapy safety with a prostate cancer diagnosis | Quarterly Podcast Summary #3

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this quarterly podcast summary (QPS) episode, Peter summarizes ...

11 Nov 202425min

#324 ‒ Metabolism, energy balance, and aging: How diet, calorie restriction, and macronutrients influence longevity and metabolic health | Eric Ravussin, Ph.D.

#324 ‒ Metabolism, energy balance, and aging: How diet, calorie restriction, and macronutrients influence longevity and metabolic health | Eric Ravussin, Ph.D.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Eric Ravussin is a world-renowned expert on obesity, metabolism, a...

4 Nov 20242h 9min

#323 - CRISPR and the future of gene editing: scientific advances, genetic therapies, disease treatment potential, and ethical considerations | Feng Zhang, Ph.D.

#323 - CRISPR and the future of gene editing: scientific advances, genetic therapies, disease treatment potential, and ethical considerations | Feng Zhang, Ph.D.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Feng Zhang, a professor of neuroscience at MIT and a pioneering fi...

28 Okt 20242h 5min

#322 - Bone health for life: building strong bones, preventing age-related loss, and reversing osteoporosis with evidence-based exercise | Belinda Beck, Ph.D.

#322 - Bone health for life: building strong bones, preventing age-related loss, and reversing osteoporosis with evidence-based exercise | Belinda Beck, Ph.D.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Belinda Beck, founder of The Bone Clinic and a leading authority o...

21 Okt 20241h 39min

#321 – Dopamine and addiction: navigating pleasure, pain, and the path to recovery | Anna Lembke, M.D.

#321 – Dopamine and addiction: navigating pleasure, pain, and the path to recovery | Anna Lembke, M.D.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Anna Lembke is the Chief of the Stanford Addiction Medicine Dual D...

14 Okt 20242h 21min

#320 – AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape

#320 – AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this "Ask Me Anything" (AMA) episode, Peter dives back into the...

7 Okt 202420min

#319 ‒ Peter's key takeaways on liver health, heart rate variability, AI in medicine, klotho, and lactate metabolism | Quarterly Podcast Summary #2

#319 ‒ Peter's key takeaways on liver health, heart rate variability, AI in medicine, klotho, and lactate metabolism | Quarterly Podcast Summary #2

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this quarterly podcast summary (QPS) episode, Peter summarizes ...

30 Sep 202428min

Populärt inom Hälsa

somna-med-henrik
rss-bara-en-till-om-missbruk-medberoende-2
rss-jossan-nina
inga-beiga-morsor
alska-oss
rss-vuxna-pa-latsas
not-fanny-anymore
johannes-hansen-podcast
angestpodden
sexnoveller-deluxe
rss-viktmedicinpodden
sa-in-i-sjalen
brottarbroder
sova-med-dan-horning
rss-psykoterapipodden
rss-the-house-podcast-3
rss-sjalsligt-avkladd
rss-basta-livet
sex-pa-riktigt-med-marika-smith
tyngre-traningssnack